Science Current Events | Science News | Brightsurf.com
 

Estrogen Current Events | Estrogen News | 11

Sort By: Page Views | Date

Disabling mouse enzyme increases fertility
Changing the sugars attached to a hormone produced in the pituitary gland increased fertility levels in mice nearly 50 percent, a research group at Washington University School of Medicine in St. Louis has found.   view more (2008-05-19)

Study aims to find which breast cancer patients need chemotherapy
Most postmenopausal women with small breast tumors don't need chemotherapy to reduce their recurrence risk after lumpectomy.   view more (2007-03-13)

Drug developed at UC Davis may prevent breast cancer, treat post-menopausal vaginal atrophy
A tamoxifen-like drug developed by UC Davis and Finnish researchers, now in clinical testing as a treatment for vaginal atrophy, may also help to prevent breast cancer, two preliminary studies suggest.   view more (2005-11-03)

Newer chemotherapies improve outcomes for some types of breast cancer
An updated analysis of findings from three major consecutive clinical trials of breast cancer treatment conducted over the past twenty years indicates that women who have breast cancer with lymph node involvement and estrogen-receptor negative tumors have a lower rate of recurrence and risk of death with treatment with newer chemotherapies.   view more (2006-04-12)

Hormone therapy plus physical activity reduce belly fat, body fat percentage after menopause
Older women who take hormone therapy to relieve menopausal symptoms may get the added benefit of reduced body fat if they are physically active, according to a new study.   view more (2009-06-10)

Biomarker May Be an Early Predictor of Advanced Breast Cancer
Researchers have identified a molecule that may be more accurate than existing biological signposts used to predict which breast cancers will develop into advanced forms of the disease.   view more (2007-11-06)

Study identifies causes of bone loss in breast cancer survivors
Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss.   view more (2008-11-20)

Tamoxifen chemoprevention tied to early detection of breast cancer
The drug tamoxifen does not prevent or treat estrogen receptor (ER) negative breast cancer, but it can make the disease easier to find, researchers report in the Oct. 1 Journal of the National Cancer Institute.   view more (2008-10-08)

More older women with early stage breast cancer choose chemotherapy, GUMC researchers say
A new study examining treatment decision-making by older women with early stage breast cancer shows that 45 percent of women would choose to get chemotherapy after surgery -- a figure higher than the national average of women getting the additional treatment.   view more (2009-05-15)

Bisphenol A linked to metabolic syndrome in human tissue
New research from the University of Cincinnati (UC) implicates the primary chemical used to produce hard plastics-bisphenol A (BPA)-as a risk factor for metabolic syndrome and its consequences.   view more (2008-09-05)

Popular osteoporosis drugs triple risk of bone necrosis
A University of British Columbia and Vancouver Coastal Health Research Institute study has found that a popular class of osteoporosis drugs nearly triples the risk of developing bone necrosis, a condition that can lead to disfigurement and incapacitating pain.   view more (2008-01-16)

Uncovering Sex-Change Secrets Of The Black Sea Bass
In a former cowshed on the edge of the University of New Hampshire campus, David Berlinsky, assistant professor of zoology, peers into a big blue plastic tub.   view more (2006-04-12)

Estrogen Helps Drive Distinct, Aggressive Form of Prostate Cancer
Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers.   view more (2008-05-28)

New computational technique can predict drug side effects
Early identification of adverse effects of drugs before they are tested in humans is crucial in developing new therapeutics, as unexpected effects account for a third of all drug failures during the development process.   view more (2007-12-12)

Protein marker associated with positive outcome in invasive breast cancer
Researchers at Sunnybrook and Women's College Health Sciences Centre have found a new protein marker linked to positive outcome in patients with breast cancer.   view more (2005-11-16)

Black cohosh does not relieve menopausal hot flashes, Group Health researchers find
The popular herbal supplement black cohosh does not relieve hot flashes among women going through menopause, according to a study by researchers from Group Health Cooperative, a Seattle-based health care system.   view more (2006-12-19)

Targeting helpers of heat shock proteins could help treat cancer, cardiovascular disease
Dissecting how heat shock protein 90 gets steroid receptors into shape to use hormones like estrogen and testosterone could lead to targeted therapies for hormone-driven cancers, such as breast and prostate, that need them as well, Medical College of Georgia researchers say.   view more (2009-06-23)

Soy found protective against localized prostate cancer
The largest study examining the relationship between the traditional soy-rich Japanese diet and development of prostate cancer in Japanese men has come to a seemingly contradictory conclusion: intake of isoflavone chemicals, derived largely from soy foods, decreased the risk of localized prostate cancer but increased the risk of advanced prostate... view more... (2007-03-16)

Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.   view more (2008-01-15)

Osteoporosis drug Fosamax linked to heart problem
omen who have used Fosamax are nearly twice as likely to develop the most common kind of chronically irregular heartbeat (atrial fibrillation) than are those who have never used it, according to research from Group Health and the University of Washington published in the April 28 Archives of Internal Medicine.   view more (2008-04-29)
Sort By: Page Views | Date
© 2009 BrightSurf.com